Plato Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.64M Sell
9,440
-55
-0.6% -$29.8K 0.31% 72
2025
Q4
$5.53M Sell
9,495
-239
-2% -$135K 0.36% 64
2025
Q3
$4.69M Hold
9,734
0.32% 70
2025
Q2
$3.93M Buy
9,734
+968
+11% +$405K 0.3% 78
2025
Q1
$4.41M Buy
8,766
+36
+0.4% +$19.5K 0.37% 62
2024
Q4
$4.56M Buy
8,730
+1,183
+16% +$650K 0.34% 65
2024
Q3
$4.66M Buy
7,547
+523
+7% +$310K 0.38% 55
2024
Q2
$3.88M Buy
7,024
+296
+4% +$170K 0.36% 64
2024
Q1
$3.91M Buy
6,728
+6,114
+996% +$3.43M 0.4% 61
2023
Q4
$326K Buy
+614
New +$297K 0.4% 60

Other funds holding TMO

Plato Investment Management's TMO Position: Q1 2026 in Review

Plato Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 0.58% in Q1 2026, selling an estimated $29.8K and leaving 9,440 shares worth $4.64M. The position accounts for 0.31% of the portfolio, ranked #72.

Plato Investment Management first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. The position peaked at $5.53M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Plato Investment Management held 9,440 shares of Thermo Fisher Scientific worth $4.64M as of Q1 2026.
  • Plato Investment Management sold 55 Thermo Fisher Scientific shares in Q1 2026, an estimated $29.8K.
  • Thermo Fisher Scientific made up 0.31% of Plato Investment Management's portfolio in Q1 2026, its #72 holding.
  • Plato Investment Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
  • Plato Investment Management's Thermo Fisher Scientific position peaked at $5.53M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.